BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17385050)

  • 1. p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance.
    Hong SM; Cho H; Moskaluk CA; Yu E; Zaika AI
    J Mol Histol; 2007 Jun; 38(3):167-75. PubMed ID: 17385050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
    Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
    Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
    Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
    Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
    Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
    Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
    Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
    J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
    Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
    J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 and p73, the ancestors of p53.
    Dötsch V; Bernassola F; Coutandin D; Candi E; Melino G
    Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004887. PubMed ID: 20484388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 and p73 transcriptionally regulate genes involved in DNA repair.
    Lin YL; Sengupta S; Gurdziel K; Bell GW; Jacks T; Flores ER
    PLoS Genet; 2009 Oct; 5(10):e1000680. PubMed ID: 19816568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p63 and p73 in ameloblastomas.
    Kumamoto H; Ohki K; Ooya K
    J Oral Pathol Med; 2005 Apr; 34(4):220-6. PubMed ID: 15752257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of p63 and p73 antibodies for cross-reactivity.
    Rosenbluth JM; Johnson K; Tang L; Triplett T; Pietenpol JA
    Cell Cycle; 2009 Nov; 8(22):3702-6. PubMed ID: 19855172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
    Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas.
    Chen YK; Huse SS; Lin LM
    Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):451-5. PubMed ID: 12969350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of the expression of p53, p63 and p73 in nasal and paranasal sinus carcinoma].
    Zhang T; Jia H; Wang J; Shan Y; Luo S; Tang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(20):919-21. PubMed ID: 19119599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
    Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
    World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.